Marcus Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $622K | Sell |
23,350
-550
| -2% | -$14.7K | 1.81% | 26 |
|
|
2018
Q2 | $903K | Buy |
23,900
+950
| +4% | +$35.9K | 2.87% | 12 |
|
|
2018
Q1 | $750K | Buy |
22,950
+7,325
| +47% | +$239K | 2.76% | 13 |
|
|
2017
Q4 | $761K | Sell |
15,625
-36,725
| -70% | -$1.79M | 2.91% | 14 |
|
|
2017
Q3 | $2.83M | Sell |
52,350
-18,250
| -26% | -$986K | 4.02% | 5 |
|
|
2017
Q2 | $3.97M | Sell |
70,600
-27,075
| -28% | -$1.52M | 3.4% | 4 |
|
|
2017
Q1 | $3.83M | Buy |
97,675
+4,975
| +5% | +$195K | 3.57% | 4 |
|
|
2016
Q4 | $2.08M | Buy |
92,700
+11,000
| +13% | +$247K | 2.24% | 21 |
|
|
2016
Q3 | $1.86M | Buy |
81,700
+6,550
| +9% | +$149K | 1.78% | 27 |
|
|
2016
Q2 | $1.77M | Buy |
75,150
+2,125
| +3% | +$50.2K | 1.87% | 26 |
|
|
2016
Q1 | $1.49M | Buy |
73,025
+18,000
| +33% | +$367K | 1.64% | 28 |
|
|
2015
Q4 | $2.83M | Buy |
+55,025
| New | +$2.83M | 3.01% | 12 |
|